Previous close | 0.7500 |
Open | 0.7500 |
Bid | 0.0000 |
Ask | 2.0000 |
Strike | 60.00 |
Expiry date | 2024-10-18 |
Day's range | 0.7500 - 0.7500 |
Contract range | N/A |
Volume | |
Open interest | 2 |
Beam Therapeutics (BEAM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
One important metric to look for in a stock is an 80 or higher Relative Strength Rating. Beam Therapeutics stock now clears that threshold, with a jump from 65 to 85 Wednesday. IBD's proprietary rating tracks market leadership with a 1 (worst) to 99 (best) score.
Beam Therapeutics' (BEAM) current chief financial officer, Terry-Ann Burrell, is set to step down from her role on Aug 9. The stock falls 4.7%.